Journal Mobile Options
Table of Contents
Vol. 158, No. 4, 2012
Issue release date: June 2012
Section title: Original Paper
Int Arch Allergy Immunol 2012;158:411–417
(DOI:10.1159/000334286)

The Burden Associated with Ocular Symptoms in Allergic Rhinitis

Klossek J.M. · Annesi-Maesano I. · Pribil C. · Didier A.
aService ORL, Hôpital Jean Bernard, CHU Poitiers, Poitiers, bEPAR, INSERM, and cMedical School Saint-Antoine, UPMC Paris VI, Paris, dGlaxoSmithKline, Marly le Roi, and eService de Pneumologie-Allergologie, Hôpital Larrey, CHU de Toulouse, Toulouse, France

Do you have an account?

Register and profit from personalized services (MyKarger) Login Information

Please create your User ID & Password





Contact Information









I have read the Karger Terms and Conditions and agree.

Register and profit from personalized services (MyKarger) Login Information

Please create your User ID & Password





Contact Information









I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger (new!)
  • Unrestricted printing, no saving restrictions for personal use
  • Reduced rates with a PPV account
read more

Direct: USD 38.00
Account: USD 26.50

Select

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select


Article / Publication Details

First-Page Preview
Abstract of Original Paper

Received: 7/22/2011 2:09:49 PM
Accepted: 9/30/2011
Published online: 4/5/2012
Issue release date: June 2012

Number of Print Pages: 7
Number of Figures: 2
Number of Tables: 3

ISSN: 1018-2438 (Print)
eISSN: 1423-0097 (Online)

For additional information: http://www.karger.com/IAA

Abstract

Background: Ocular symptoms remain widely neglected while they concern the majority of subjects with allergic rhinitis (AR) and impair their daily activities. We describe the characteristics of ocular symptoms in subjects suffering from AR in the French INSTANT study and their impact on daily activities. Methods: This cross-sectional observational survey was carried out in November 2006 using face-to-face interviews. Results: 31.7% of the population-based sample (n = 4,019) suffered from AR and 52.0% of AR subjects (n = 663) described ocular symptoms. Men had significantly less ocular symptoms than women (odds ratio 0.71, 95% CI 0.57–0.89). 57.5% of subjects suffered from ocular symptoms for >5 years, 30.2% for >6 months in the past 12 months, and 92.2% during the pollen season. The troublesome ocular symptoms were itching eyes (51.1%), watery eyes (38.6%), red eyes (6.6%) and swollen eyelids (3.6%). The trigger factors were pollens (51.3%), household dust and mites (34.8%), pets (12.2%) and air pollution (3.8%). Ocular symptoms had a negative impact on daily activities (blurred sight 47.8%, reduction in daily activities 38.8%, reduction in efficacy at work 25.8%, sleep disturbances 16.3%, and sick leave 12.9%). They were diagnosed in 38.9% of subjects and followed up in 34.8%. Treatment for ocular symptoms was prescribed to 35.4% of subjects and to 61.9% of subjects with a regular follow-up care. Conclusions: This survey confirms the impact of ocular symptoms on AR patients’ lives and suggests that they are still neglected and undertreated.


  

Author Contacts

Correspondence to: Prof. Alain Didier
Service de Pneumologie-Allergologie
Hôpital Larrey, CHU de Toulouse
FR–31059 Toulouse (France)
Tel. +33 56 777 1830, E-Mail   

Article Information

Received: July 22, 2011
Accepted after revision: September 30, 2011
Published online: April 5, 2012
Number of Print Pages : 7
Number of Figures : 2, Number of Tables : 3, Number of References : 27
Additional supplementary material is available online - Number of Parts : 1

  

Publication Details

International Archives of Allergy and Immunology

Vol. 158, No. 4, Year 2012 (Cover Date: June 2012)

Journal Editor: Valenta R. (Vienna)
ISSN: 1018-2438 (Print), eISSN: 1423-0097 (Online)

For additional information: http://www.karger.com/IAA


Article / Publication Details

First-Page Preview
Abstract of Original Paper

Received: 7/22/2011 2:09:49 PM
Accepted: 9/30/2011
Published online: 4/5/2012
Issue release date: June 2012

Number of Print Pages: 7
Number of Figures: 2
Number of Tables: 3

ISSN: 1018-2438 (Print)
eISSN: 1423-0097 (Online)

For additional information: http://www.karger.com/IAA


Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.